BlossomHill Therapeutics, Inc. (BLSM) vs CytomX Therapeutics, Inc. (CTMX)
A side-by-side comparison of BlossomHill Therapeutics, Inc. and CytomX Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BLSM
BlossomHill Therapeutics, Inc.
$19.94HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CTMX
CytomX Therapeutics, Inc.
$2.58HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BLSM vs CTMX
growth of $100 · dividends reinvested · last 1yBLSM +24.6% (+24.6%/yr)CTMX -23.4% (-23.4%/yr)BLSM compounded faster over this window
BLSM CTMX
BLSM vs CTMX: by the numbers
- •BLSM is the larger company ($580M vs $562M market cap).
- •Both run net losses; BLSM's is the smaller (0.00% vs -435.21% net margin).
Metrics side by side
Valuation
| Metric | BLSM | CTMX |
|---|---|---|
| P/S ratio | N/A | 30.69 |
| P/B ratio | N/A | 1.86 |
Profitability
| Metric | BLSM | CTMX |
|---|---|---|
| Gross margin | 0.00% | 98.63% |
| Operating margin | 0.00% | -29.35% |
| Net margin | 0.00% | -435.21% |
| ROE | N/A | -26.37% |
| ROIC | -43.41% | -25.42% |
Growth (annualized)
| Metric | BLSM | CTMX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 2.18% |
| Total return CAGR (5Y) | N/A | -12.01% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.